Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Advances in Experimental Medicine and Biology
|
January 1, 1996
Saquinavir: an HIV proteinase inhibitor
K Bragman
Cancer Treatment Reviews
|
June 1, 1988
Carboplatin: current status and future prospects
R Canetta, K Bragman, L Smaldone, et al.
Annals of the New York Academy of Sciences
|
January 1, 1985
New methodology for liposome targeting to specific cells
D Papahadjopoulos, T Heath, K Bragman, et al.
Lancet (London, England)
|
June 10, 1995
Emerging proteinase inhibitors
V Kitchen, F Stewart, K Bragman, et al.
Oncology (Williston Park, N.Y.)
|
July 1, 1987
Clinical status of carboplatin
R Canetta, C Franks, L Smaldone, et al.
International Journal of Clinical Practice
|
February 3, 2006
Guiding Principles for Pharmaceutical Physicians from the Ethical Issues Committee of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the UK
R Bickerstaffe, P Brock, J-M Husson, et al.
International Journal of Clinical Practice
|
February 3, 2006
Ethics and pharmaceutical medicine -- the full report of the Ethical Issues Committee of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the UK
R Bickerstaffe, P Brock, J-M Husson, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1986
Treatment of acute leukaemia with m-AMSA in combination with cytosine arabinoside
H S Dhaliwal, M S Shannon, M J Barnett, et al.
Journal of the National Cancer Institute
|
October 4, 1989
Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatin
C Mangioni, G Bolis, S Pecorelli, et al.
The Journal of Antimicrobial Chemotherapy
|
June 1, 1997
Emergence of resistant variants of HIV in vivo during monotherapy with the proteinase inhibitor saquinavir
K J Ives, H Jacobsen, S A Galpin, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Advances in Experimental Medicine and Biology
|
January 1, 1996
Saquinavir: an HIV proteinase inhibitor
K Bragman
Cancer Treatment Reviews
|
June 1, 1988
Carboplatin: current status and future prospects
R Canetta, K Bragman, L Smaldone, et al.
Annals of the New York Academy of Sciences
|
January 1, 1985
New methodology for liposome targeting to specific cells
D Papahadjopoulos, T Heath, K Bragman, et al.
Lancet (London, England)
|
June 10, 1995
Emerging proteinase inhibitors
V Kitchen, F Stewart, K Bragman, et al.
Oncology (Williston Park, N.Y.)
|
July 1, 1987
Clinical status of carboplatin
R Canetta, C Franks, L Smaldone, et al.
International Journal of Clinical Practice
|
February 3, 2006
Guiding Principles for Pharmaceutical Physicians from the Ethical Issues Committee of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the UK
R Bickerstaffe, P Brock, J-M Husson, et al.
International Journal of Clinical Practice
|
February 3, 2006
Ethics and pharmaceutical medicine -- the full report of the Ethical Issues Committee of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the UK
R Bickerstaffe, P Brock, J-M Husson, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1986
Treatment of acute leukaemia with m-AMSA in combination with cytosine arabinoside
H S Dhaliwal, M S Shannon, M J Barnett, et al.
Journal of the National Cancer Institute
|
October 4, 1989
Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatin
C Mangioni, G Bolis, S Pecorelli, et al.
The Journal of Antimicrobial Chemotherapy
|
June 1, 1997
Emergence of resistant variants of HIV in vivo during monotherapy with the proteinase inhibitor saquinavir
K J Ives, H Jacobsen, S A Galpin, et al.
Page
of 2